Cowen & Co. analyst Boris Peaker downgrades Macrogenics (NASDAQ:MGNX) from Outperform to Market Perform.
HSBC Downgrades Mosaic to Reduce, Lowers Price Target to $43
HSBC analyst Santhosh Seshadri downgrades Mosaic (NYSE:MOS) from Hold to Reduce and lowers the price target from $45 to $43.